ZEISEL, Mirjam B; LUCIFORA, Julie; MASON, William S; SUREAU, Camille; BECK, Jürgen; LEVRERO, Massimo; KANN, Michael; KNOLLE, Percy A; BENKIRANE, Monsef; DURANTEL, David; MICHEL, Marie-Louise; AUTRAN, Brigitte; FRANÇOIS-LOÏC, Cosset; STRICK-MARCHAND, Hélène; TRÉPO, Christian; KAO, Jia-Horng; CARRAT, Fabrice; LACOMBE, Karine; SCHINAZI, Raymond F; BARRÉ-SINOUSSI, Françoise; DELFRAISSY, Jean-François; ZOULIM, Fabien

doi:10.1136/gutjnl-2014-308943

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

Langue

Article de revue

Ce document a été publié dans

2015-08, vol. 64, n° 8, p. 1314-26

BMJ Publishing Group

Résumé en anglais

HBV infection is a major cause of liver cirrhosis and hepatocellular carcinoma. Although HBV infection can be efficiently prevented by vaccination, and treatments are available, to date there is no reliable cure for the >240 million individuals that are chronically infected worldwide. Current treatments can only achieve viral suppression, and lifelong therapy is needed in the majority of infected persons. In the framework of the French National Agency for Research on AIDS and Viral Hepatitis 'HBV Cure' programme, a scientific workshop was held in Paris in June 2014 to define the state-of-the-art and unanswered questions regarding HBV pathobiology, and to develop a concerted strategy towards an HBV cure. This review summarises our current understanding of HBV host-interactions leading to viral persistence, as well as the roadblocks to be overcome to ultimately address unmet medical needs in the treatment of chronic HBV infection.< Réduire

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure.

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche